Koers Omni Bio Pharmaceutical Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2013 | - | Omzet 2014 | - | Marktkapitalisatie | 10,89 mln. 10,19 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2013 | -7 mln. -6,55 mln. | Nettowinst (verlies) 2014 | -2 mln. -1,87 mln. | EV/omzet 2013 | - |
Nettoschuld 2013 | 441K 413K | Nettoschuld 2014 | 752K 704K | EV/omzet 2014 | - |
K/w-verhouding 2013 |
-1,5
x | K/w-verhouding 2014 |
-4,18
x | Werknemers | - |
Dividendrendement 2013 * |
-
| Dividendrendement 2014 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+15,19% | 122 mld. | |
+19,91% | 113 mld. | |
+8,24% | 22,84 mld. | |
-19,80% | 20,72 mld. | |
-16,19% | 16,51 mld. | |
-13,45% | 16,39 mld. | |
-44,35% | 15,83 mld. | |
+2,13% | 13,49 mld. | |
+66,67% | 11,67 mld. |